All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @dr.houcem on TikTok · 18s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @dr.houcem's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00The third step which I will do is to make sure that you can take the right position and that it will be helpful to you.
  2. 0:06It will be very easy to see, and I will take the right position to make this position so that it will be easier to get the right position.
  3. 0:13And that will be the next step to make sure.

Dapoxetine for premature ejaculation: what the evidence actually shows

Dr.Houcem Hedhli

TikTok creator

852.9K viewsWatch on TikTok

Quick answer

This video caption claims dapoxetine is the sole pharmacological option for premature ejaculation, while the spoken transcript contains no coherent medical content. The claim is contradicted by published evidence supporting multiple efficacious agents including off-label SSRIs and topical anesthetics. The recommendation for pre- and post-treatment evaluation aligns with ISSM clinical guidelines for premature ejaculation management.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Dapoxetine for premature ejaculation: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Dapoxetine for premature ejaculation: what the evidence actually shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Dapoxetine for premature ejaculation: what the evidence actually shows" from Dr.Houcem Hedhli. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video caption claims dapoxetine is the sole pharmacological option for premature ejaculation, while the spoken transcript contains no coherent medical content.

The reason this review is not generic is the source wording and the canonical claim label "trt urology doctor menhealth." In this clip, the useful excerpt is: "The third step which I will do is to make sure that you can take the right position and that it will be helpful to you." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

At least 4 other pharmacological options exist for premature ejaculation, including off-label daily paroxetine, sertraline, clomipramine, and topical lidocaine-prilocaine spray.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

This video caption claims dapoxetine is the sole pharmacological option for premature ejaculation, while the spoken transcript contains no coherent medical content.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This video caption claims dapoxetine is the sole pharmacological option for premature ejaculation, while the spoken transcript contains no coherent medical content. The claim is contradicted by published evidence supporting multiple efficacious agents including off-label SSRIs and topical anesthetics. The recommendation for pre- and post-treatment evaluation aligns with ISSM clinical guidelines for premature ejaculation management.
  • Dapoxetine has RCT support: Pryor et al. (2006, European Urology) showed a roughly threefold increase in ejaculation latency versus placebo at the 60mg dose.
  • At least 4 other pharmacological options exist for premature ejaculation, including off-label daily paroxetine, sertraline, clomipramine, and topical lidocaine-prilocaine spray.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Dapoxetine has RCT support: Pryor et al. (2006, European Urology) showed a roughly threefold increase in ejaculation latency versus placebo at the 60mg dose.
  • At least 4 other pharmacological options exist for premature ejaculation, including off-label daily paroxetine, sertraline, clomipramine, and topical lidocaine-prilocaine spray.
  • Paroxetine may outperform dapoxetine on latency time in some analyses: McMahon et al. (2016, Journal of Sexual Medicine) found it produced the largest IELT increases among studied SSRIs.
  • Dapoxetine is contraindicated in patients with cardiac conduction abnormalities, MAOI use, or significant liver impairment. No mass-audience medication recommendation should omit this.
  • Pre-treatment evaluation is clinically supported. DSM-5 and ISSM criteria distinguish lifelong from acquired premature ejaculation, which influences whether pharmacological or behavioral treatment is first-line.
  • Dapoxetine is not FDA-approved in the United States. Its availability varies significantly by country, and presenting it as universally accessible is misleading.
  • The spoken transcript in this video contains no recoverable medical information, meaning the entire medical claim rests on a caption alone, without any verbal explanation or clinical context.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @dr.houcem actually say?

The caption is doing more work than the transcript here. @dr.houcem's caption states that dapoxetine is "the only available medication" for delaying ejaculation, that it's available in pharmacies, and that evaluation before and after treatment is necessary. The spoken transcript, however, is largely incoherent positional filler language that doesn't map onto any specific medical claim. So this fact-check focuses primarily on what the caption asserts, because that's where the actual medical content lives.

To be direct: the caption makes a factual claim about dapoxetine's exclusivity as a pharmacological option for premature ejaculation. That claim deserves scrutiny.

Does the science back this up?

Dapoxetine is a real drug with real evidence behind it. No argument there. But calling it "the only available medication" is simply incorrect, and it's the kind of simplification that can mislead patients who might benefit from other options.

Dapoxetine is a short-acting selective serotonin reuptake inhibitor approved in several countries, including parts of Europe and the Middle East, specifically for premature ejaculation. A large randomized controlled trial by Pryor et al. (2006, European Urology) found dapoxetine 60mg increased intravaginal ejaculation latency time roughly threefold compared to placebo. That's legitimate evidence.

But other SSRIs, particularly paroxetine and sertraline used off-label, have comparable or in some analyses stronger efficacy. McMahon et al. (2016, Journal of Sexual Medicine) reviewed pharmacological options and documented daily-dosed paroxetine as producing the largest increases in ejaculation latency among SSRIs. Topical anesthetics like lidocaine-prilocaine spray also carry regulatory approval in multiple countries. Dapoxetine is a good option. It is not the only one.

What did they get wrong (or right)?

Credit where it's due: the recommendation for evaluation before and after treatment is clinically sound. Premature ejaculation can have psychological, relational, and physiological components, and treating it without assessment is poor practice. The International Society for Sexual Medicine guidelines support structured evaluation, so that part of the caption holds up.

What falls apart is the exclusivity claim. Stating dapoxetine is "the only available medication" is either outdated or geographically narrow thinking presented as universal fact. In Tunisia, where this creator appears to be based, the regulatory landscape may limit what's formally approved, but that context is absent from the video. Presenting a regional availability issue as a global medical fact is misleading to an 852,000-person audience that spans multiple countries.

There's also no mention of contraindications. Dapoxetine is contraindicated in patients with cardiac conditions, those taking monoamine oxidase inhibitors, or those with significant hepatic impairment. A video recommending a medication to a mass audience without flagging these is a gap worth naming.

What should you actually know?

If you're looking into premature ejaculation treatment, dapoxetine is a legitimate first-line option in countries where it's approved, but it isn't operating in a vacuum of alternatives. Your options, depending on where you live and your health profile, include off-label daily SSRIs, topical anesthetics, behavioral techniques, and combination approaches.

The "before and after assessment" point is genuinely important. Premature ejaculation is defined clinically as ejaculation occurring within approximately one minute of penetration on most occasions, causing distress, per the DSM-5 criteria. That definition matters because self-diagnosis is unreliable. Men with lifelong versus acquired premature ejaculation may respond differently to pharmacological versus psychological intervention.

Dapoxetine is taken on demand, 1-3 hours before sexual activity, which makes it convenient. But it comes with side effects including nausea, dizziness, and orthostatic hypotension. Anyone considering it should have a proper clinical consultation, not a TikTok video as their primary source.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr.Houcem Hedhli · TikTok creator

852.9K views on this video

الدواء الوحيد المتوفر لتأخير سرعة القذف هو الدبوكسيتين متوفر في الصيدليات و لكن ضروري الفحص قبل و بعد أخذ الدواء لتقييم الحالة#urology #doctor #menhealth

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about dapoxetine has rct support: pryor et al. (2006, european urology)?

Dapoxetine has RCT support: Pryor et al. (2006, European Urology) showed a roughly threefold increase in ejaculation latency versus placebo at the 60mg dose.

What does the video say about at least 4 other pharmacological options exist for premature ejaculation,?

At least 4 other pharmacological options exist for premature ejaculation, including off-label daily paroxetine, sertraline, clomipramine, and topical lidocaine-prilocaine spray.

What does the video say about paroxetine may outperform dapoxetine on latency time in some analyses:?

Paroxetine may outperform dapoxetine on latency time in some analyses: McMahon et al. (2016, Journal of Sexual Medicine) found it produced the largest IELT increases among studied SSRIs.

What does the video say about dapoxetine?

Dapoxetine is contraindicated in patients with cardiac conduction abnormalities, MAOI use, or significant liver impairment. No mass-audience medication recommendation should omit this.

What does the video say about pre-treatment evaluation?

Pre-treatment evaluation is clinically supported. DSM-5 and ISSM criteria distinguish lifelong from acquired premature ejaculation, which influences whether pharmacological or behavioral treatment is first-line.

What does the video say about dapoxetine?

Dapoxetine is not FDA-approved in the United States. Its availability varies significantly by country, and presenting it as universally accessible is misleading.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr.Houcem Hedhli, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.